ORIGINAL ARTICLESEffects of repeated doses of ivermectin on ocular onchocerciasis: community-based trial in Sierra Leone
References (31)
- et al.
Studies on onchocerciasis in the United Cameroon Republic I. Comparison of populations with and without Onchocerca volvulus
Trans R Soc Trop Med Hyg
(1974) - et al.
Immunopathology of ocular onchocerciasis 2. Anti-retinal autoantibodies in serum and ocular fluids
Ophthalmology
(1987) - et al.
Visual loss during oral diethylcarbamazine treatment for onchocerciasis
Lancet
(1979) - et al.
Side-effects of ivermectin in treatment of onchocerciasis
Lancet
(1989) - et al.
Ocular involvement in patients with onchocerciasis after repeated treatment with ivermectin
Am J Ophthalmol
(1990) - et al.
Longitudinal study of lesions of the posterior segment in onchocerciasis
Ophthalmology
(1990) - et al.
Changes in ocular onchocerciasis four and twelve months after community-based treatment with ivermectin in a holoendemic onchocerciasis focus
Trans R Soc Trop Med Hyg
(1990) - et al.
Community-based treatment with ivermectin
Lancet
(1988) - et al.
A community trial of ivermectin for onchocerciasis in Sierre Leone: clinical and parasitological response to the initial dose
Trans R Soc Trop Med Hyg
(1991) - et al.
Onchocerciasis in Sierra Leone 3: relationships between the eye lesions and microfilarial prevalence and intensity
Trans R Soc Trop Med Hyg
(1988)
third report
(1987)
Onchocerciasis
Commun Eye Health
(1989)
Onchocerciasis
(1974)
Ocular Onchocerciasis
Trop Dis Bull
(1977)
Ocular onchocerciasis
Trop Doct
(1985)
Cited by (31)
Whitcup and Nussenblatt’s Uveitis: Fundamentals and Clinical Practice
2021, Whitcup and Nussenblatt's Uveitis: Fundamentals and Clinical PracticeControl of Onchocerciasis
2006, Advances in ParasitologyCitation Excerpt :Ivermectin (Mectizan®, Merck & Co.) is a semisynthetic macrocyclic lactone derived from Streptomyces avermitilis, which was registered for the treatment of human onchocerciasis in October 1987 in France. Ivermectin was the first microfilaricide suitable for large-scale onchocerciasis treatment (Awadzi et al., 1985; De Sole et al., 1989; Remme et al., 1989; Prod’hon et al., 1991; Whitworth et al., 1991; Collins et al., 1992). Donated free by Merck & Co.
The impact of five years of annual ivermectin treatment on skin microfilarial loads in the onchocerciasis focus of Asubende, Ghana
1994, Transactions of the Royal Society of Tropical Medicine and HygieneONCHOCERCIASIS. Ivermectin and onchocercal optic nerve lesions
1993, The LancetA community trial of ivermectin for onchocerciasis in sierra leone: Clinical and parasitological responses to four doses given at six-monthly intervals
1992, Transactions of the Royal Society of Tropical Medicine and Hygiene
Copyright © 1991 Published by Elsevier Ltd.